Literature DB >> 7843273

Involvement of early and late lysosomes in the degradation of mannosylated ligands by rat liver endothelial cells.

R Kjeken1, A Brech, T Løvdal, N Roos, T Berg.   

Abstract

The intracellular transport and degradation of endocytosed mannosylated albumin (Man-BSA) was studied in cell cultures of rat liver endothelial cells by subcellular fractionation, fluorescence microscopy, and electron microscopy. The ligand used for subcellular fractionation experiments was labeled with 125I-labeled tyramine cellobiose or 131I-labeled tyramine cellobiose. The labeled degradation products are trapped in the degradative compartments and may therefore serve as markers for these compartments. Cell fractionation was performed using Nycodenz gradients. The cell fractionation experiments demonstrated that the ligand sequentially occupied three compartments of increasing density. After 15 min it was mainly found in large cisternal organelles that banded in the gradient at about 1.09 g/ml. These organelles were rab5 positive and showed a peripher distribution in the fluorescence microscope. Degradation of ligand started after 30-60 min and this coincided with its transfer to a electron lucent vesicle with a density of 1.12 g/ml. After > 1 h, degradation products started to accumulate in perinuclear, electron-dense lysosomes that banded in the gradient at 1.15 g/ml. The density distribution of lysosomal beta-acetylglucosaminidase coincided with the densest organelle. The results obtained show that the degradation of ligand takes place sequentially in two types of lysosomes. The early lysosome is an electronlucent vesicle of low density, whereas the terminal lysosome is an electron-dense organelle with higher density and a more perinuclear distribution. The main degradation of the ligand takes place in the early lysosome. The transfer of ligand and degradation products from the early to the late lysosome is slow. Texas red-labeled ovalbumin (OVA) coincided with lysosomes labeled with OVA-Bodipy 24 h in advance only after 4-6 h.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7843273     DOI: 10.1006/excr.1995.1037

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Wortmannin-sensitive trafficking steps in the endocytic pathway in rat liver endothelial cells.

Authors:  R Kjeken; S A Mousavi; A Brech; G Griffiths; T Berg
Journal:  Biochem J       Date:  2001-07-15       Impact factor: 3.857

2.  Endocytosis and degradation of serglycin in liver sinusoidal endothelial cells.

Authors:  Berit Falkowska-Hansen; Inger Oynebråten; Lars Uhlin-Hansen; Bård Smedsrød
Journal:  Mol Cell Biochem       Date:  2006-05-30       Impact factor: 3.396

3.  Hepatic disposal of advanced glycation end products during maturation and aging.

Authors:  Dmitri Svistounov; Ana Oteiza; Svetlana N Zykova; Karen Kristine Sørensen; Peter McCourt; Andrew J McLachlan; Robert S McCuskey; Bård Smedsrød
Journal:  Exp Gerontol       Date:  2013-03-24       Impact factor: 4.032

4.  Endo-lysosomal vesicles positive for Rab7 and LAMP1 are terminal vesicles for the transport of dextran.

Authors:  William H Humphries; Craig J Szymanski; Christine K Payne
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240

5.  Homotypic lysosome fusion in macrophages: analysis using an in vitro assay.

Authors:  D M Ward; J D Leslie; J Kaplan
Journal:  J Cell Biol       Date:  1997-11-03       Impact factor: 10.539

6.  Scavenger properties of cultivated pig liver endothelial cells.

Authors:  Kjetil H Elvevold; Geir I Nedredal; Arthur Revhaug; Bård Smedsrød
Journal:  Comp Hepatol       Date:  2004-08-12

7.  Intracellular trafficking of begomoviruses in the midgut cells of their insect vector.

Authors:  Wen-Qiang Xia; Yan Liang; Yao Chi; Li-Long Pan; Jing Zhao; Shu-Sheng Liu; Xiao-Wei Wang
Journal:  PLoS Pathog       Date:  2018-01-25       Impact factor: 6.823

8.  Receptor-Mediated Endocytosis of VEGF-A in Rat Liver Sinusoidal Endothelial Cells.

Authors:  Seyed Ali Mousavi; Frode Skjeldal; Marita Sporstøl Fønhus; Linda Hofstad Haugen; Winnie Eskild; Trond Berg; Oddmund Bakke
Journal:  Biomed Res Int       Date:  2019-09-10       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.